ATP Assays Market: Current Analysis and Forecast (2023-2030)

ATP assays are essential tools for studying cellular metabolism, evaluating cell viability, assessing drug efficacy, and measuring microbial contamination. These assays typically involve the use of luciferase enzymes that catalyze the reaction between ATP and luciferin, resulting in the emission of light. The amount of light produced is directly proportional to the ATP concentration in the sample, allowing for quantitative measurements. The increasing research and development activities in the pharmaceutical and biotechnology industries, along with the increasing prevalence of chronic diseases are driving the growth of the ATP assay market.

ATP Assays Market is expected to grow at a strong CAGR of 8% during the forecast period (2023-2030) owing to the rising geriatric population and the high sensitivity of the population towards contaminants. For instance, according to World Health Organisation, by 2030, one in six people in the world will be over the age of 60. By then, the share of the population aged 60 and over will increase from 1 billion in 2020 to 1.4 billion.

Based on product, the market is segmented into consumables & accessories, and instruments. As per our analysis, the consumables & accessories segment acquired a major share in 2022. Consumables and accessories are essential components of ATP assays, and they include various reagents, kits, plates, and detection systems. The high usage of consumables & kits in the ATP assays, along with their cost-effectiveness are the major attributing factors to the large share of the segment.

Based on the application, the market is segmented into contamination testing, disease testing, drug discovery and development, and others. The drug discovery and development segment is expected to grow with a higher CAGR in the ATP assays market during the forecast period. The increasing research and development for drug development, along with the increasing R&D expenditure are the major attributing factors for the growth of the segment. For instance, As per the World Bank, the global R&D expenditure accounted for 2.63% of the Global GDP in 2020.

For a better understanding of the market adoption of the industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Rest of World. North America held dominating share of the ATP Assays market in 2022. The presence of well-established healthcare infrastructure, along with the increasing healthcare expenditure in the countries is the major attributing factor for the market growth in North America. For instance, the healthcare expenditure of the United States increased from USD 107.1 billion in 2019 to USD 238.3 billion in 2020.

Some of the major players operating in the market include: Agilent Technologies, Inc; Thermo Fisher Scientific Inc.; Abcam plc; PerkinElmer Inc; BioThema; Danaher; Promega Corporation; Merck KGaA; Lonza; 3M.